$292.39
+0.94%Standex International Corporation, together with subsidiaries, manufactures and sells various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and current sense and advanced planar transformer technologies, value added assemblies, and mechanical packaging, as well as custom wound transformers and inductors for low and high frequency applications. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries. The Scientific segment offers temperature controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets. The Specialty Solutions segment manufactures and sells refrigerated, heated and dry merchandizing display cases, custom fluid pump solutions, single and double acting telescopic, and piston rod hydraulic cylinders. Standex International Corporation was founded in 1955 and is headquartered in Salem, New Hampshire.
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
SXI โข NYSE
| Standex International Corporation Cash Flow Statement | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | Jun 2008 | Jun 2007 | Jun 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
55.8M | 73.6M | 139.2M | 61.5M | 38.5M | 41M | 47.2M | 36.6M | 46.6M | 52.2M | 55.2M | 49.7M | 45.3M | 46.9M | 36.1M | 28M | -1.9M | 19.3M | 21.2M | 20.9M | |
35.4M | 28.1M | 28.5M | 29.7M | 33.2M | 32.3M | 30.9M | 29.2M | 20.3M | 18M | 16.7M | 14.6M | 15.5M | 13.5M | 14.2M | 14.4M | 15.5M | 17.1M | 15.2M | 12M | |
0.0 | -2.8M | -7.1M | -2M | 836K | 5.6M | -3.5M | 7.4M | -121K | -6.8M | -249K | -3.3M | -2.4M | 2.4M | -416K | 5.3M | -3.6M | -467K | 1.1M | -2.2M | |
0.0 | 9.8M | 11.7M | 11.2M | 8.4M | 7M | 4.4M | 5M | 5M | 5.1M | 3.8M | 6.6M | 3.3M | 3.8M | 3.8M | 3.8M | 2.4M | 0.0 | 0.0 | 0.0 | |
787K | -11.1M | -55.8M | 2.7M | 6.2M | -18M | 2M | -16.4M | -1.2M | 13.5M | -5.6M | 3.7M | -7.9M | -8.5M | -4.7M | -1.4M | 21.6M | 2.5M | 385K | 3.5M | |
(27.7M) | (28M) | (26.2M) | (18M) | (17.2M) | (18.7M) | (24M) | (22.1M) | (20.4M) | (24.8M) | (12.9M) | (14M) | (14M) | (13.4M) | (5.7M) | (9.1M) | (5M) | (10.3M) | (0.0) | (0.0) | |
-22.4M | -5.1M | -25.6M | -25.4M | -3.6M | -20.7M | -7.6M | 3.1M | -7.2M | -1.7M | -5.8M | -1M | 6.2M | -14.4M | 7.3M | -28.8M | 5.3M | 7.1M | 879K | -2.3M | |
69.6M | 92.7M | 90.8M | 77.7M | 83.6M | 47.2M | 73.3M | 64.9M | 63.4M | 80.3M | 64M | 70.3M | 60.2M | 43.7M | 56.3M | 21.4M | 39.4M | 44.7M | 25.5M | 31.7M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-28.3M | -20.3M | -24.3M | -23.9M | -21.8M | -21.5M | -34.4M | -26.5M | -26.4M | -17.9M | -22.6M | -18.8M | -14.1M | -9.9M | -33.2M | -4.7M | -5.9M | -9.9M | -10.3M | -15.1M | |
-478.9M | -41.1M | (67M) | -13M | -15.7M | -622K | -127.9M | -10.4M | -153.8M | -13.7M | -57.1M | -23.1M | -39.6M | (0.0) | -26.6M | (0.0) | -5.6M | (0.0) | -95.4M | -16.5M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (33.2M) | (0.0) | -695K | (0.0) | (31.1M) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.7M | 0.0 | 639K | 8.1M | 1.4M | 4.3M | |
3.8M | -270K | -1.2M | 5.8M | -1.6M | 21.5M | 112.6M | 4.7M | 1.2M | 2.8M | 1.2M | 8.7M | 1.1M | 18.5M | -7.4M | 10.3M | 4.4M | 4.2M | -642K | 4.3M | |
-503.4M | -61.6M | (41.6M) | -31M | -39.1M | -617K | -49.7M | -32.3M | -179.1M | -28.8M | -78.5M | -33.2M | -52.7M | (8.6M) | -28.2M | (5.7M) | -7.2M | (2.4M) | -74M | -23M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-9.9M | -31.8M | -25.5M | -31.4M | -21.2M | -10.4M | -33.4M | -2.7M | -7.8M | -5.6M | -10.4M | -7.8M | -8.5M | -5.5M | -5.2M | -698K | -831K | 24K | -1.9M | -2.3M | |
403.2M | -25M | -1.7M | -25M | 0.0 | 1.2M | 4.8M | -1.3M | 99.5M | -10M | 58M | -5M | -785K | -1.6M | -41.7M | -1M | -107.3M | -33.9M | 51M | 12.1M | |
-15M | -13.9M | -13M | -12.2M | -11.4M | -10.6M | -9.8M | -8.9M | -7.9M | -6.8M | -5.8M | -4.8M | -3.9M | -3.4M | -2.9M | -2.5M | -8.4M | -10.3M | -10.3M | -10.3M | |
-9.9M | -31.8M | -25.5M | -31.4M | -21.2M | -10.4M | -33.4M | -2.7M | -7.8M | -5.6M | -10.4M | -7.8M | -8.5M | -5.5M | -5.2M | -1.1M | -1.7M | -926K | -4.1M | -8.5M | |
2.2M | 1.5M | 174K | -752K | 917K | 866K | 219K | 915K | 849K | 1.7M | 2.8M | 1.7M | 2M | 965K | 589K | 0.0 | 66.7M | 0.0 | 242K | -314K | |
380.5M | -69.2M | -40M | -69.4M | -31.7M | -19M | -38.2M | -11.9M | 84.7M | -20.7M | 44.6M | -14.8M | -10.9M | -9.5M | -49.2M | -4.2M | -49.9M | -44.1M | 39.1M | -741K | |
CASH FLOW SUMMARY | ||||||||||||||||||||
3.7M | -3.3M | -1.5M | -8.8M | 4.8M | -2M | -1.9M | 289K | -2.5M | -4.9M | -8.3M | 895K | -263K | -2.4M | 1.9M | 1.8M | -2.1M | 1.7M | 898K | 1M | |
-49.7M | -41.5M | 90.9M | -31.5M | 17.6M | 25.7M | -16.5M | 21M | -33.4M | 25.9M | 21.9M | 23.2M | -3.7M | 40.3M | -19.2M | 24.6M | -19.7M | 4.6M | -8.5M | 8.9M | |
154.2M | 195.7M | 104.8M | 136.4M | 118.8M | 93.1M | 109.6M | 88.6M | 122M | 96.1M | 74.3M | 51.1M | 54.7M | 14.4M | 33.6M | 9M | 28.7M | 24.1M | 32.6M | 23.7M | |
104.5M | 154.2M | 195.7M | 104.8M | 136.4M | 118.8M | 93.1M | 109.6M | 88.6M | 122M | 96.1M | 74.3M | 51.1M | 54.7M | 14.4M | 33.6M | 9M | 28.7M | 24.1M | 32.6M | |
41.3M | 72.4M | 66.5M | 53.8M | 61.8M | 25.7M | 39M | 38.4M | 37M | 62.5M | 41.5M | 51.5M | 46M | 33.7M | 23.2M | 16.7M | 33.5M | 34.8M | 15.2M | 16.5M |
SXI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 14, 2026 | May 12, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 04, 2026 | January 29, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 02, 2026 | December 31, 2025 | 2025 | |
10-K/A 10-K/A 2025 FY (Amended) FY | December 31, 2025 | June 30, 2025 | 2025 | |
10-K/A 10-K/A 2024 FY (Amended) FY | December 29, 2025 | June 30, 2024 | 2024 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 05, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 31, 2025 | October 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 31, 2025 | October 21, 2025 | 2025 |
Continue your SXI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.